Does cytokine gene polymorphism affect steroid responses in idiopathic nephrotic syndrome?

Indian Journal of Medical Sciences

Volumn 62, Issue 10, 2008, Pages 383-391

  Tripathi, Gaurav ^a   Jafar, Tabrez ^b   Mandal, Kaushik ^a   Mahdi, Abbas ^b   Awasthi, Shally ^c   Sharma, Raj ^a,b   Kumar, Alok ^a,b   Gulati, Sanjeev ^a,b   Agrawal, Suraksha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c Sanjay Gandhi Post Graduate Institute of Medical Sciences ^*

Author keywords

Idiopathic nephrotic syndromes; IL 4; IL 6; Steroid resistant; Steroid responsive; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 6; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHI SQUARE TEST; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEREDITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; DRUG RESISTANCE; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOCORTICOIDS; HUMANS; INFANT; INTERLEUKIN-4; INTERLEUKIN-6; MALE; NEPHROTIC SYNDROME; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57149091742     PISSN: 00195359     EISSN: 19983654     Source Type: Journal    
DOI: 10.4103/0019-5359.44017     Document Type: Article

References (26)

1. Reidy K, Kaskel FJ. Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol 2007;22:350-4.
2. Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, et al. A case of unfulfilled expectations: Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2006;21:603-10.
3. Stachowski J, Barth C, Michałkiewicz J, Krynicki T, Jarmoliñski T, Runowski D, et al. Th1/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome. Pediatr Nephrol 2000;14:779-85.
4. Del Rio M, Kaskel F. Evaluation and management of steroid-unresponsive nephrotic syndrome. Curr Opin Pediatr 2008;20:151-6.
5. Kimata H, Fujimoto M, Furusho K. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur J Immunol 1995;25:1497-501.
6. Gulati S, Godbole M, Singh U, Gulati K, Srivastava A Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis 2003;41:1163-9.
7. van der Paardt M, Crusius JB, García-González MA, Baudoin P, Kostense PJ, Alizadeh BZ, et al. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology (Oxford) 2002;41:1419-23.
8. Mann CL, Davies MB, Stevenson VL, Leary SM, Boggild MD, Ko Ko C, et al. Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuroimmunol 2002;129:197-204.
9. Syrjänen J, Hurme M, Lehtimäki T, Mustonen J, Pasternack A. Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int 2002;61:1079-85.
10. Kobayashi Y, Arakawa H, Suzuki M, Takizawa T, Tokuyama K, Morikawa A. Polymorphisms of interleukin-4 - related genes in Japanese children with minimal change nephrotic syndrome. Am J Kidney Dis. 2003;42:271-6.
11. Liu HM, Shen Q, Xu H, Yang Y. Significance of polymorphisms in variable number of tandem repeat region of interleukin-4 gene in recurrence of childhood steroid sensitive nephrotic syndrome. Zhonghua Er Ke Za Zhi 2005;43:431-3.
12. Acharya B, Shirakawa T, Pungky A, Damanik P, Massi MN, Miyata M, et al. Polymorphism of the interleukin-4, interleukin-13, and signal transducer and activator of transcription 6 genes in Indonesian children with minimal change nephrotic syndrome. Am J Nephrol 2005;25:30-5.
13. Masutani K, Taniguchi M, Nakashima H, Yotsueda H, Kudoh Y, Tsuruya K, et al. Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy Nephrol Dial Transplant 2004;19:580-6.
14. DeMichele A, Martin AM, Mick R, Gor P, Wray L, Klein-Cabral M, et al. Interleukin-6-174G3C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res 2003;63:8051-6.
15. Castellucci L, Menezes E, Oliveira J, Magalhaes A, Guimaraes LH, Lessa M, et al. IL6 -174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis 2006;194:519-27.
16. Tischendorf JJ, Yagmur E, Scholten D, Vidacek D, Koch A, Winograd R, et al. The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet 2007;34:413-8.
17. Schotte H, Schlüter B, Rust S, Assmann G, Domschke W, Gaubitz M. Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology 2001;40:393-400.
18. Mittal RD Manchanda PK. Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics 2007;59:159-65.
19. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
20. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;1:3195-9.
21. Bustos C, González E, Muley R, Alonso JL, Egido J. Increase of tumor necrosis factor α synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994;24:799-805.
22. Matsumoto K. Spontaneous and LPS-stimulated release of tumor necrosis factor-alpha by peripheral blood monocytes in patients with focal glomerular sclerosis. Nephron 1995;70:118-9.
23. Brasier A, Li J, Wimbish K. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 1996;27:1009-17.
24. Schachter AD, Strehlau J, Zurakowski D, Vasconcellos L, Kim YS, Zheng XX, et al. Increased NF-κB and angiotensinogen gene expression in post-transplant recurrent focal segmental glomerulosclerosis. Transplantation 2000;70:1107-10.
25. Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans. Am J Kidney Dis 1993;21:251-9.
26. Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciuté A, Remy P, et al. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol 2001;12:1648-58.